California state funding advances clinical trials

Thursday, May 5, 2011 01:00 PM

The California Institute for Regenerative Medicine (CIRM) has been awarded taxpayer funding for the first time to study an experimental stem cell treatment on humans, according to The San Diego Union-Tribune.

The $25 million grant went to Calif.-based biopharmaceutical company Geron, which has begun injecting immature versions of special neural cells derived from embryonic stem cells into patients paralyzed by spinal cord injuries.

Geron’s phase I clinical trial is designed to assess the safety and tolerance of GRNOPC1 in humans. The therapy already has been successfully tested in rats.

The company is recruiting participants within 14 days of suffering a spinal cord injury through seven sites around the U.S.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs